ε-Aminocaproic Acid in Angiographically Negative Subarachnoid Hemorrhage Patients Is Safe: A Retrospective Review of 83 Consecutive Patients
- 5 September 2011
- journal article
- review article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 70 (3) , 702-706
Abstract
Background: ε-Aminocaproic acid (EACA) has been used to reduce the rate of cerebral aneurysm rerupture before definitive treatment. In centers administering EACA to patients with a subarachnoid hemorrhage (SAH), patients eventually diagnosed with angiographically negative subarachnoid hemorrhage (ANSAH) may also initially receive EACA, perhaps placing them at increased risk for ischemic complications.Objective: To evaluate the effect of short-term EACA on outcomes and secondary measures in patients with ANSAH.Methods: We conducted a retrospective study of 454 consecutive SAH patients over a 2-year period under a current protocol for EACA use. Patients were excluded if a source for the SAH was discovered, yielding a total of 83 ANSAH patients. The patients were assigned to groups that did or did not receive EACA. The primary end points of the study were ischemic complications, pulmonary emboli, vasospasm, ventriculoperitoneal shunting rates, and outcomes.Results: Statistical analysis yielded no significant difference between the 2 arms with respect to any of the end points: vasospasm (P = .65), deep vein thrombosis (P = .51), pulmonary embolism (P = 1.0), stroke (P = 1.0), myocardial infarction (P = 1.0), and ventriculoperitoneal shunt (P = .57). There was no statistically significant outcome difference using the modified Rankin Scale (P = .30).Conclusion: Short-term (<72 hour) application of EACA does not result in an increase in adverse events in patients with ANSAH.Keywords
This publication has 21 references indexed in Scilit:
- Short-Term Antifibrinolytic Therapy Before Early Aneurysm Treatment in Subarachnoid Hemorrhage: Effects on Rehemorrhage, Cerebral Ischemia, and HydrocephalusNeurosurgery, 2010
- Impact of a Protocol for Acute Antifibrinolytic Therapy on Aneurysm Rebleeding After Subarachnoid HemorrhageStroke, 2008
- YIELD OF FURTHER DIAGNOSTIC WORK-UP OF CRYPTOGENIC SUBARACHNOID HEMORRHAGE BASED ON BLEEDING PATTERNS ON COMPUTED TOMOGRAPHIC SCANSNeurosurgery, 2008
- Sentinel Headache and the Risk of Rebleeding After Aneurysmal Subarachnoid HemorrhageStroke, 2006
- Antifibrinolytic Therapy for Aneurysmal Subarachnoid HemorrhageStroke, 2003
- Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapyJournal of Neurosurgery, 1997
- Subarachnoid hemorrhage without detectable aneurysm. A review of the causes.Stroke, 1993
- Rebleeding of ruptured intracranial aneurysms in the acute stageSurgical Neurology, 1987
- Spontaneous subarachnoid hemorrhage and negative cerebral panangiographyJournal of Neurosurgery, 1986
- Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 1984